A clinical trial to evaluate AZD7648 alone and in combination with other anti-cancer agents in patients with advanced cancers.

Trial Identifier:	D9170C00001
Sponsor:	AstraZeneca
Collaborator:	PAREXEL International
NCTID::	NCT03907969
Start Date:	October 2019
Primary Completion Date:	December 2022
Study Completion Date:	December 2022
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	English (UK) Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	London, GB, EC1A 7BE
GB	London, GB, SE1 9RT
GB	Newcastle upon Tyne, GB, NE7 7DN
US, CT	New Haven, CT, US, 06510
US, TX	Houston, TX, US, 77030

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company